Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2014, Article ID 237535, 7 pages
http://dx.doi.org/10.1155/2014/237535
Research Article

Downregulation of Type II Diabetes Mellitus and Maturity Onset Diabetes of Young Pathways in Human Pancreatic Islets from Hyperglycemic Donors

Department of Clinical Sciences, Diabetes & Endocrinology, Lund University Diabetes Center, Skåne University Hospital, Lund University, 20502 Malmö, Sweden

Received 22 July 2014; Revised 22 September 2014; Accepted 25 September 2014; Published 14 October 2014

Academic Editor: Daisuke Koya

Copyright © 2014 Jalal Taneera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Zimmet, “Globalization, coca-colonization and the chronic disease epidemic: can the doomsday scenario be averted?” Journal of Internal Medicine, vol. 247, no. 3, pp. 301–310, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. X.-F. Huang and J.-Z. Chen, “Obesity, the PI3K/Akt signal pathway and colon cancer,” Obesity Reviews, vol. 10, no. 6, pp. 610–616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. B. R. Henke and S. M. Sparks, “Glycogen phosphorylase inhibitors,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 8, pp. 845–857, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. U. Özcan, Q. Cao, E. Yilmaz et al., “Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes,” Science, vol. 306, no. 5695, pp. 457–461, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Trayhurn and I. S. Wood, “Signalling role of adipose tissue: adipokines and inflammation in obesity,” Biochemical Society Transactions, vol. 33, no. 5, pp. 1078–1081, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Andersson, A. H. Olsson, J. L. S. Esguerra et al., “Reduced insulin secretion correlates with decreased expression of exocytotic genes in pancreatic islets from patients with type 2 diabetes,” Molecular and Cellular Endocrinology, vol. 364, no. 1-2, pp. 36–45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. H. Olsson, B. T. Yang, E. Hall et al., “Decreased expression of genes involved in oxidative phosphorylation in human pancreatic islets from patients with type 2 diabetes,” European Journal of Endocrinology, vol. 165, no. 4, pp. 589–595, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. K. Mootha, C. M. Lindgren, K.-F. Eriksson et al., “PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes,” Nature Genetics, vol. 34, no. 3, pp. 267–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. T. R. Golub, D. K. Slonim, P. Tamayo et al., “Molecular classification of cancer: class discovery and class prediction by gene expression monitoring,” Science, vol. 286, no. 5439, pp. 531–527, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Subramanian, P. Tamayo, V. K. Mootha et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15545–15550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Sweet-Cordero, S. Mukherjee, A. Subramanian et al., “An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis,” Nature Genetics, vol. 37, no. 1, pp. 48–55, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Bourquin, S. Schreiber, S. Beck, G. Hartmann, and S. Endres, “Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer,” International Journal of Cancer, vol. 118, no. 11, pp. 2790–2795, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Zhou, G. M. Pupo, P. Gupta et al., “A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration,” BMC Genomics, vol. 13, no. 1, article 677, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Skov, S. Knudsen, M. Olesen, M. L. Hansen, and L. M. Rasmussen, “Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes,” Cardiovascular Diabetology, vol. 11, article 15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Taneera, S. Lang, A. Sharma et al., “A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets,” Cell Metabolism, vol. 16, no. 1, pp. 122–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. C. Del Rosario, V. Ossowski, W. C. Knowler, C. Bogardus, L. J. Baier, and R. L. Hanson, “Potential epigenetic dysregulation of genes associated with MODY and type 2 diabetes in humans exposed to a diabetic intrauterine environment: an analysis of genome-wide DNA methylation,” Metabolism: Clinical and Experimental, vol. 63, no. 5, pp. 654–660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Barroso, J. Luan, R. P. S. Middelberg et al., “Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action,” PLoS Biology, vol. 1, no. 1, p. E20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M.-T. Gulllam, E. Hummler, E. Schaerer et al., “Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2,” Nature Genetics, vol. 17, no. 3, pp. 327–330, 1997. View at Google Scholar · View at Scopus
  19. T. L. Hoffman, E. Blanco, A. Lane et al., “Glucose metabolism and insulin secretion in a patient with ABCC8 mutation and Fanconi-Bickel syndrome caused by maternal isodisomy of chromosome 3,” Clinical Genetics, vol. 71, no. 6, pp. 551–557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. C. Florez, K. A. Jablonski, S. E. Kahn et al., “Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the diabetes prevention program,” Diabetes, vol. 56, no. 2, pp. 531–536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. L. Gloyn, E. R. Pearson, J. F. Antcliff et al., “Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes,” The New England Journal of Medicine, vol. 350, no. 18, pp. 1838–1849, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Bonnefond, J. Philippe, E. Durand et al., “Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene,” PLoS ONE, vol. 7, no. 6, Article ID e37423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Le Lay and R. Stein, “Involvement of PDX-1 in activation of human insulin gene transcription,” Journal of Endocrinology, vol. 188, no. 2, pp. 287–294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. M. Sachdeva, K. C. Claiborn, C. Khoo et al., “Pdx1 (MODY4) regulates pancreatic beta cell susceptibility to ER stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 45, pp. 19090–19095, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Hamasaki, Y. Yamada, T. Kurose et al., “Adult pancreatic islets require differential pax6 gene dosage,” Biochemical and Biophysical Research Communications, vol. 353, no. 1, pp. 40–46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Nishi, M. Sasahara, T. Shono et al., “A case of novel de novo paired box gene 6 (PAX6) mutation with early-onset diabetes mellitus and aniridia,” Diabetic Medicine, vol. 22, no. 5, pp. 641–644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Hang and R. Stein, “MafA and MafB activity in pancreatic β cells,” Trends in Endocrinology and Metabolism, vol. 22, no. 9, pp. 364–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Artner, B. Blanchi, J. C. Raum et al., “MafB is required for islet β cell maturation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 10, pp. 3853–3858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Itkin-Ansari, E. Marcora, I. Geron et al., “NeuroD1 in the endocrine pancreas: localization and dual function as an activator and repressor,” Developmental Dynamics, vol. 233, no. 3, pp. 946–953, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Y. Kristinsson, E. T. Thorolfsdottir, B. Talseth et al., “MODY in Iceland is associated with mutations in HNF-1α and a novel mutation in NeuroD1,” Diabetologia, vol. 44, no. 11, pp. 2098–2103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Wang, B. R. Gauthier, K. A. Hagenfeldt-Johansson, M. Iezzi, and C. B. Wollheim, “Foxa2 (HNF3β) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release,” Journal of Biological Chemistry, vol. 277, no. 20, pp. 17564–17570, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Yadranji Aghdam, Z. Gurel, A. Ghaffarieh, C. M. Sorenson, and N. Sheibani, “High glucose and diabetes modulate cellular proteasome function: implications in the pathogenesis of diabetes complications,” Biochemical and Biophysical Research Communications, vol. 432, no. 2, pp. 339–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Liu, S. Yu, W. Xu, and J. Xu, “Enhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2131–2140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. L. Hribal, L. Perego, S. Lovari et al., “Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans,” The FASEB Journal, vol. 17, no. 10, pp. 1340–1342, 2003. View at Google Scholar · View at Scopus
  35. P. Osmark, O. Hansson, A. Jonsson, T. Rönn, L. Groop, and E. Renström, “Unique splicing pattern of the TCF7L2 gene in human pancreatic islets,” Diabetologia, vol. 52, no. 5, pp. 850–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Kaminska, T. Kuulasmaa, S. Venesmaa et al., “Adipose tissue TCF7L2 Splicing is regulated by weight loss and associates with glucose and fatty acid metabolism,” Diabetes, vol. 61, no. 11, pp. 2807–2813, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. N. C. Bramswig, L. J. Everett, J. Schug et al., “Epigenomic plasticity enables human pancreatic α to β cell reprogramming,” Journal of Clinical Investigation, vol. 123, no. 3, pp. 1275–1284, 2013. View at Publisher · View at Google Scholar · View at Scopus